Healthy human
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals who receive adequate explanation for the purpose and content of this trial and provide written informed consent for participation by their own free will. 2. Men and women over 30 years old. 3.Those with a fasting blood glucose level of less than 126 mg/dL and HbA1c of less than 6.5%. 4.Non smoker.
Exclusion criteria
Exclusion criteria: 1.Individuals with chronic disease medication. 2.Individuals who take medicines that may affect blood glucose metabolism, take foods for specified health use or foods with functional claims, at least 5 days a week. 3.Individuals with food allergies caused by cocoa, dairy ingredients, soy, eggs, wheat, shrimp, crab, peanuts, buckwheat, almonds, oranges, cashews, kiwifruits, walnuts ,sesame, bananas, peaches, apple, and gelatin. 4.Individuals aware of FOS intolerance. 5.Individuals who can not eat 60g of chocolate. 6.Men less than 40 kg and women less than 30 kg in weight. 7.Individuals comprehensively judged by the investigator to have distinct abnormalities in BMI, blood pressure, hematology test values, and biochemical test values in the preliminary test. 8.Individuals who are pregnant or breastfeeding. 9.Individuals who have participated in other clinical trials within one month before obtaining consent to participate in this study, or those who plan to participate in other clinical studies between the acquisition of consent to participate in this study and the end of the second examination. 10.Others who are judged to be inappropriate as subjects by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference of area under the curve of blood glucose levels from baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.blood glucose levels (measured values, difference from baseline, area under the curve, Cmax, difference of Cmax of blood glucose levels from baseline, Tmax) 2.insulin levels (measured values, difference from baseline, area under the curve, difference of area under the curve of insulin levels from baseline, Cmax, difference of Cmax of insulin levels from baseline ,Tmax) | — |
Countries
Japan
Contacts
Niigata Bio-Research Park, Inc Business promotion division